Particle therapy

Heidelberg University Hospital Treats First Patient Using Carbon Ion Therapy With RayStation

Retrieved on: 
Wednesday, August 14, 2019
Medical physics, Radiation therapy, Physical sciences, Natural sciences, Health, Proton therapy, University Hospital Heidelberg, Tomotherapy, Therapy, Ion beam, Particle therapy, Gerhard Kraft

STOCKHOLM, Aug. 14, 2019 /PRNewswire/ -- In April 2018, RayStation was selected as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT), which is the leading German facility for proton and carbon ion therapy and part of the Heidelberg University Hospital.

Key Points: 
  • STOCKHOLM, Aug. 14, 2019 /PRNewswire/ -- In April 2018, RayStation was selected as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT), which is the leading German facility for proton and carbon ion therapy and part of the Heidelberg University Hospital.
  • HIT has long expertise in advanced radiation therapy techniques and has been performing proton therapy and carbon ion therapy for the past 10 years.
  • Heidelberg University Hospital also treats patients using TomoTherapy, which is the focus of another cooperation between HIT and RaySearch.
  • Johan Lf, CEO of RaySearch, says: "We are proud to see Heidelberg's first carbon ion treatment using RayStation, and it is gratifying that all European centers have now chosen RayStation for carbon ion therapy.

United States $16 Billion Proton Therapy Markets to 2025

Retrieved on: 
Tuesday, August 13, 2019
Medical physics, Radiation therapy, Health, Academic disciplines, Proton therapy, Radiobiology, Therapy, Proton, Indiana University Health Proton Therapy Center, Particle therapy

DUBLIN, Aug. 13, 2019 /PRNewswire/ -- The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 13, 2019 /PRNewswire/ -- The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.
  • The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025.
  • In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase.
  • The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

United States Proton Therapy Markets 2009-2018 & 2019-2025: Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 13, 2019
Radiology, Pharmaceutical, Health, Medical physics, Health sciences, Health, Academic disciplines, Proton therapy, Radiobiology, Radiation therapy, Therapy, PROTON Holdings, Proton, Indiana University Health Proton Therapy Center, Particle therapy

The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.
  • The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025.
  • In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase.
  • The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

Ten Years Ago Since First Order of RayStation Treatment Planning System

Retrieved on: 
Wednesday, July 31, 2019
Radiation therapy, Medical physics, Particle therapy, Physics, Physical sciences, Academic disciplines

STOCKHOLM, July 31, 2019 /PRNewswire/ -- This summer marks the ten-year anniversary since the first order of the treatment planning system RayStation.

Key Points: 
  • STOCKHOLM, July 31, 2019 /PRNewswire/ -- This summer marks the ten-year anniversary since the first order of the treatment planning system RayStation.
  • After a few years in practice, RaySearch decided to develop its own treatment planning system, named RayStation.
  • Since this first order, RayStation has become the market leader in treatment planning for particle therapy globally.
  • As of today, RayStation is selected by 55 particle centers as their treatment planning system.

MedAustron Treats First Patient Using Carbon Ion Therapy With RayStation

Retrieved on: 
Monday, July 29, 2019
Radiation therapy, Medical physics, Health sciences, Medicine, Physical sciences, Proton therapy, Therapy, Particle therapy, Gerhard Kraft

STOCKHOLM, July 29, 2019 /PRNewswire/ -- MedAustron, a leading Austrian center specializing in ion therapy and research, has treated its first patient using carbon ion therapy.

Key Points: 
  • STOCKHOLM, July 29, 2019 /PRNewswire/ -- MedAustron, a leading Austrian center specializing in ion therapy and research, has treated its first patient using carbon ion therapy.
  • The center started treating patients in 2016 and has used RayStation for proton therapy since the outset.MedAustron was also the first RaySearch customer for carbon ion therapy treatment planning in RayStation.
  • Markus Stock, Head of Medical Physics at MedAustron, says: "We are excited and happy to announce our first successful treatment of a patient with carbon ion therapy.
  • MedAustron is a cutting-edge center for ion therapy and research, specialized in advanced cancer treatment using protons and carbon ions.

RaySearch Receives Largest Order to Date: MedAustron Chooses RayStation, RayCare and RayCommand for Two Proton and Carbon Ion Treatment Facilities

Retrieved on: 
Friday, June 28, 2019
Radiation therapy, Medical physics, Health sciences, Health, Medicine, Therapy, Oncology, Radiation treatment planning, Particle therapy

The RayCommand treatment control system (TCS) is the latest extension of the RaySearch product line, and its announcement in 2018 has generated high interest worldwide.

Key Points: 
  • The RayCommand treatment control system (TCS) is the latest extension of the RaySearch product line, and its announcement in 2018 has generated high interest worldwide.
  • The system acts as a link between the treatment machine and the treatment planning and oncology information systems.
  • A major clinical benefit of using RayStation, RayCare and RayCommand together is that they enable true online adaptive therapy.
  • MedAustron is a cutting-edge center for ion therapy and research, specialized in advanced cancer treatment using protons and carbon ions.

RaySearch to Exhibit the Latest News for Particle Therapy at PTCOG 58

Retrieved on: 
Monday, June 10, 2019
Medical physics, Radiation therapy, Physical sciences, Physics, Academic disciplines, Radiobiology, Particle therapy

STOCKHOLM, June 10, 2019 /PRNewswire/ -- RaySearch will exhibit at the PTCOG 58 congress in Manchester, UK, during 12-15 June.

Key Points: 
  • STOCKHOLM, June 10, 2019 /PRNewswire/ -- RaySearch will exhibit at the PTCOG 58 congress in Manchester, UK, during 12-15 June.
  • The latest particle news in the treatment planning system RayStation and the latest updates in the next generation oncology information system (OIS) RayCare* will be on show.
  • RaySearch is a proud world leader in particle therapy planning and workflow software, with well received features in RayStation.
  • RayStation is selected by 52 particle radiotherapy clinics in the world spread over 18 countries, and the number is increasing.

Varian Showcasing Latest Proton Therapy Systems and Technology at PTCOG Conference 58

Retrieved on: 
Thursday, June 6, 2019
Radiation therapy, Medical physics, Health sciences, Health, Medicine, Proton therapy, Particle therapy, Palo Alto, California, Therapy

PALO ALTO, Calif., June 6, 2019 /PRNewswire/ --Varian (NYSE: VAR) announced it will be showcasing its new ProBeam360 proton therapy system*, June 12th-15th in Manchester, United Kingdom at the 58th PTCOG Conference (Particle Therapy Co-Operative Group).

Key Points: 
  • PALO ALTO, Calif., June 6, 2019 /PRNewswire/ --Varian (NYSE: VAR) announced it will be showcasing its new ProBeam360 proton therapy system*, June 12th-15th in Manchester, United Kingdom at the 58th PTCOG Conference (Particle Therapy Co-Operative Group).
  • Designed for next-generation proton therapy, the ProBeam 360 system offers uncompromised clinical capabilities, a 360-degree gantry, and RapidScan technology, which simplifies the process of motion management by delivering each field in a single breath-hold.
  • Varian Proton Solutions Users Meeting:Topics to be discussed include flash therapy research on the ProBeam system and decision support modeling with RapidPlan PT on Wednesday June 12th, 8:30am-1:30pm at Radisson Blu Edwardian.
  • Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world.For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Particle Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Retrieved on: 
Tuesday, April 16, 2019
Medical physics, Health sciences, Radiation therapy, Health, Natural sciences, Drug discovery, Health policy, Therapy, Proton therapy, Particle therapy

Less pain and high definition healing technology are major drivers of the global particle therapy market.

Key Points: 
  • Less pain and high definition healing technology are major drivers of the global particle therapy market.
  • This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global particle therapy market.
  • Based on therapy, the market has been segmented into proton therapy, carbon therapy, and other therapy.The therapy segment has been analyzed based on available centers providing particle therapy, cost-effectiveness, and preference for therapy by physicians and patients.
  • Based on end-user, the particle therapy market has been classified into hospitals, specialty clinics, ambulatory surgical centers, and others.The particle therapy market has also been segmented based on the application of particle therapy for cancer treatment.

Varian and Danish Center for Particle Therapy Announce Grand Opening and First Patient Treatments

Retrieved on: 
Thursday, February 28, 2019
Radiation therapy, Medical physics, Shipping companies, Health sciences, Health, Proton therapy, Ane Mærsk Mc-Kinney Uggla, Therapy, Particle therapy, Brain tumor, Maersk

Mller Foundation, Ane Maersk Mc-Kinney Uggla, the Varian-equipped Danish Center for Particle Therapy (DCPT) officially opened today, at the Aarhus University Hospital in Aarhus, Denmark.

Key Points: 
  • Mller Foundation, Ane Maersk Mc-Kinney Uggla, the Varian-equipped Danish Center for Particle Therapy (DCPT) officially opened today, at the Aarhus University Hospital in Aarhus, Denmark.
  • The three-treatment-room facility features the Varian ProBeam proton therapy system and has already begun patient treatments.
  • "Since treating our first patient for a brain tumor, we were quickly able to begin treatments for five other brain tumor patients.
  • Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world.For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.